COLL COLLEGIUM PHARMACEUTICAL, INC: institutional ownership and insider trading
296 funds reported holding $1.92B of COLLEGIUM PHARMACEUTICAL, INC in their latest 13F filings; in Q2 2026 funds net bought $33.3M, with 42 new positions and 29 funds selling out; over the last 12 months insiders bought $0 and sold $7.24M on the open market.
Famous investors holding COLL
- Renaissance Technologies (Renaissance Technologies): $49.5M, 0.1% of the portfolio
- Izzy Englander (Millennium Management): $26.7M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $12.2M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $3.86M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.85M, 0.0% of the portfolio
Largest institutional holders of COLL
- Banque Cantonale Vaudoise — $342M
- BlackRock, Inc. (BLK) — $197M
- VANGUARD GROUP INC — $104M
- Jupiter Topco LLC — $77.7M
- Invesco Ltd. (IVZ) — $68.1M
- JANUS HENDERSON GROUP PLC (JHG) — $60.4M
- FULLER & THALER ASSET MANAGEMENT, INC. — $59.1M
- PRINCIPAL FINANCIAL GROUP INC (PFG) — $59.1M
- STATE STREET CORP (STT, STT-PG) — $55.3M
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ — $50.9M
Recent COLL insider trades
- May 18, 2026: Freund John Gordon sold 20 shares ($681)
- May 15, 2026: Freund John Gordon sold 4,127 shares ($143K)
- May 13, 2026: Lurker Nancy sold 4,500 shares ($162K)
- May 11, 2026: Bohlin Garen G sold 8,700 shares ($323K)
5%+ owners
- Millennium Management LLC: 7.4% (Schedule 13G/A, filed Oct 8, 2026)
- JANUS HENDERSON GROUP PLC: 5.8% (Schedule 13G, filed May 15, 2026)
- Fuller & Thaler Asset Management, Inc.: 5.0% (Schedule 13G, filed Aug 14, 2026)
- Vanguard Capital Management: 5.0% (Schedule 13G, filed Jul 31, 2026)
- Invesco Ltd.: 5.0% (Schedule 13G, filed May 8, 2026)
- PRINCIPAL GLOBAL INVESTORS: 5.0% (Schedule 13G, filed Aug 5, 2026)